Search

everythinglearnresearchcommunity

for

Search:↓

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Smoking and certain health conditions like thyroid disease may make palmoplantar pustulosis harder to treat.

Severe Hidradenitis Suppurativa increases missed and unproductive workdays.

Different staff in a dermatology clinic understand mostly their own tasks, not the full clinic process.

Older hair follicle stem cells have a reduced ability to renew themselves, leading to more hair loss.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Activating Nrf2 helps wounds heal faster by increasing hair follicle stem cells.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

New treatments for sudden hair loss include oral medications and a special laser, both showing promise in hair regrowth.

Enz_MoriL from mulberry leaves helps hair growth by affecting specific cell pathways.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Compound 4 is a promising treatment for hair loss with low toxicity.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Ginsenoside Rd may help improve skin aging by increasing collagen in the skin.

Removing STAT5 from 3D-cultured human skin cells reduces their ability to grow hair.

Kaempferol helps skin stem cells grow and may improve skin thickness due to its 3-OH group.

Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.